As of 2025-05-14, the EV/EBITDA ratio of Torrent Pharmaceuticals Ltd (TORNTPHARM.NS) is 29.93. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. TORNTPHARM.NS's latest enterprise value is 1,114,984.20 mil INR. TORNTPHARM.NS's TTM EBITDA according to its financial statements is 37,257.20 mil INR. Dividing these 2 quantities gives us the above TORNTPHARM.NS EV/EBITDA ratio.
| Range | Selected | |
| Trailing P/E multiples | 16.9x - 20.8x | 19.7x |
| Forward P/E multiples | 18.2x - 23.2x | 22.1x |
| Fair Price | 1,797.60 - 2,370.34 | 2,183.71 |
| Upside | -44.5% - -26.8% | -32.5% |
| Date | EV/EBITDA |
| 2025-05-13 | 29.93 |
| 2025-05-12 | 29.86 |
| 2025-05-09 | 29.05 |
| 2025-05-08 | 29.34 |
| 2025-05-07 | 30.47 |
| 2025-05-06 | 30.51 |
| 2025-05-05 | 30.28 |
| 2025-05-02 | 30.05 |
| 2025-04-30 | 30.75 |
| 2025-04-29 | 30.71 |
| 2025-04-28 | 30.78 |
| 2025-04-25 | 29.96 |
| 2025-04-24 | 30.72 |
| 2025-04-23 | 30.81 |
| 2025-04-22 | 30.05 |
| 2025-04-21 | 30.02 |
| 2025-04-17 | 30.09 |
| 2025-04-16 | 29.86 |
| 2025-04-15 | 29.87 |
| 2025-04-11 | 28.96 |
| 2025-04-09 | 28.77 |
| 2025-04-08 | 30.11 |
| 2025-04-07 | 29.79 |
| 2025-04-04 | 30.60 |
| 2025-04-03 | 30.00 |
| 2025-04-02 | 29.62 |
| 2025-04-01 | 29.43 |
| 2025-03-28 | 29.79 |
| 2025-03-27 | 29.72 |
| 2025-03-26 | 29.74 |
| 2025-03-25 | 29.79 |
| 2025-03-24 | 30.51 |
| 2025-03-21 | 29.87 |
| 2025-03-20 | 29.84 |
| 2025-03-19 | 29.45 |
| 2025-03-18 | 28.96 |
| 2025-03-17 | 28.40 |
| 2025-03-13 | 28.23 |
| 2025-03-12 | 28.71 |
| 2025-03-11 | 28.27 |
| 2025-03-10 | 28.27 |
| 2025-03-07 | 28.55 |
| 2025-03-06 | 28.26 |
| 2025-03-05 | 27.47 |
| 2025-03-04 | 27.10 |
| 2025-03-03 | 27.49 |
| 2025-02-28 | 27.11 |
| 2025-02-27 | 27.54 |
| 2025-02-25 | 28.06 |
| 2025-02-24 | 27.84 |